HALOZYME REPORTS SECOND QUARTER 2024 FINANCIAL AND OPERATING RESULTS
Go back to HALOZYME REPORTS SECOND QUARTER 2024 FINANCIAL AND OPERATING RESULTS| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 107.41 +0.41 (0.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $107.00 | 52 Week High | $18.39 | |||
| Open | $107.96 | 52 Week Low | $6.96 | |||
| Day High | $108.23 | P/E | N/A | |||
| Day Low | $106.34 | EPS | $-0.58 | |||
| Volume | 343,125 | |||||
